AC Immune
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AC Immune and other ETFs, options, and stocks.About ACIU
AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.
ACIU Key Statistics
Stock Snapshot
As of today, AC Immune(ACIU) shares are valued at $3.02. The company's market cap stands at 298.81M, with a P/E ratio of -3.58.
On 2026-03-14, AC Immune(ACIU) stock traded between a low of $2.95 and a high of $3.22. Shares are currently priced at $3.02, which is +2.2% above the low and -6.4% below the high.
The AC Immune(ACIU)'s current trading volume is 254.95K, compared to an average daily volume of 335.81K.
In the last year, AC Immune(ACIU) shares hit a 52-week high of $4.00 and a 52-week low of $1.43.
In the last year, AC Immune(ACIU) shares hit a 52-week high of $4.00 and a 52-week low of $1.43.
ACIU News
An update from AC Immune SA ( (ACIU) ) is now available. AC Immune reported its full-year 2025 results on March 13, 2026, highlighting positive interim Phase 2...
Reports FY25 revenue CHF 3.753M vs CHF 27.309M last year. Dr. Andrea Pfeifer, CEO of AC Immune (ACIU) SA, commented: “We made significant progress towards deliv...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.